PI-3 kinase as a novel and attractive target in pediatric cancer and neuroblastoma
|
Emory University / Donald Durden |
Innovation Grants |
2008 |
Georgia |
Mechanisms of PPM1D in Medulloblastoma Tumorigenesis and Invasion |
Emory University / Robert Craig Castellino, MD |
Bridge Grants |
2012 |
Georgia |
Synergistic Differentiation Therapy in Neuroblastoma |
Duke University / Gerard Blobe, M.D./Ph.D |
Innovation Grants |
2015 |
North Carolina |
The Role of MST1 in Non-canonical Hippo Signaling in Rhabdomyosarcoma |
Duke University / Lisa Crose, Ph.D. |
'A' Award Grants |
2014 |
North Carolina |
Genetic Susceptibility to Pediatric Osteosarcoma and Interaction with Measures of Childhood Growth |
Duke University / Kyle Walsh, Ph.D. |
'A' Award Grants |
2014 |
North Carolina |
Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma |
Duke University / Corinne Mary Linardic, MD, PhD |
Innovation Grants |
2013 |
North Carolina |
Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma |
Duke University / Zachary Reitman, MD/PhD |
'A' Award Grants |
2023 |
North Carolina |
Metabolic control of p53 activation in T-ALL.
|
Duke University / Jeffrey Rathmell |
Innovation Grants |
2009 |
North Carolina |
Modeling anaplastic medulloblastoma using cerebellar stem cells
|
Duke University / Robert Wechsler-Reya, PhD |
Innovation Grants |
2009 |
North Carolina |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma |
Duke University / Michael Armstrong |
Young Investigator Grants |
2011 |
North Carolina |